Mesothelioma

...In a 2003 study, state researchers identified 17 diagnosed cases of Officials said the additional cases aren't surprising because it can take 40 or 50 years to develop The cases aren't unique to ore mining.'The 'There are important, unresolved questions that we need to address, and we believe this new study will help us provide some of the answers.'The mining study will focus on the same group of workers, comparing those who have developed Officials hope to determine what aspects of their jobs might have put workers at risk.That study is projected to cost as much as $1 million over three years.

The state will seek federal funding from the National Institute for Occupational Safety and Health and other sources.The second study, estimated to cost $250,000, would assess health risks associated w...

...In a 2003 study, state researchers identified 17 diagnosed cases of Further analysis found 35 additional cases of Officials said the additional cases aren't surprising because it can take 40 or 50 years to develop The earlier study found the 17 original The cases aren't unique to ore mining.

"The "There are important, unresolved questions that we need to address, and we believe this new study will help us provide some of the answers."The mining study will focus on the same group of workers, comparing those who have developed Officials hope to determine what aspects of their jobs might have put workers at risk.

That study is projected to cost as much as $1 million over three years.

The state will seek federal funding from the National Institute for Occupational Safety and Health and other sources.

The second study, estimated to cost $250,000, would assess health risks associa...

... Sydney science leads on cancers - National - theage.com.au NEWS register www.theage.com.au Home » National » Article Sydney science leads on cancers Email Print Normal font Large font Deborah SmithMarch 30, 2007 SYDNEY scientists have made a breakthrough in the study of a substance in cells linked to 85 per cent of cancers.

They have worked out the composition of telomerase, an enzyme that makes cancer cells immortal by preventing them dying as they age.

The research could lead to a single drug to treat almost all tumours, including breast, colon, lung and prostate.

Scott Cohen, of the Children's Medical Research Institute, said telomerase was present only in tiny amounts in cancer cells.

To determine its make-up he had to find a way to purify it from all the other enzymes.

"I had to pull out one part in a million, which is roughly a teacup of water from an Olympic swimming pool," he said.

The institute director, Roger Reddel, said telomerase was a target of anti-cancer research worldwide.

"This discovery sharpens the focus and no doubt will speed up the process of delivering successful treatments.

It's very exciting." Telomerase was co-discovered...